Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds-Reference-Cited by-同舟云学术

Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds

Published:2021-03 Issue: Volume:196 Page:113921
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Jyrkäs Juha,Tolonen Ari

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference14 articles.

1. Strategic approaches to optimizing peptide ADME properties;Di;AAPS J.,2015

2. Peptide therapeutics: current status and future directions;Fosgerau;Drug Discov. Today,2015

3. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration;Sennello;J. Pharm. Sci.,1986

4. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers;Duijkers;Hum. Reprod.,1998

5. Clinical pharmacokinetics of cyclosporin;Ptachinski;Clin. Pharmacokinet.,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism of new drug modalities research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-05

2. In vitro strategies to understand the impact of oral intake on the bioavailability and bioactivity of peptides from brewing by-products;Critical Reviews in Food Science and Nutrition;2024-07

3. Developmental toxicity assessment of neonicotinoids and organophosphate esters with a human embryonic stem cell- and metabolism-based fast-screening model;Journal of Environmental Sciences;2024-03

4. Typical neonicotinoids and organophosphate esters, but not their metabolites, adversely impact early human development by activating BMP4 signaling;Journal of Hazardous Materials;2024-03

5. Metabolite characterisation of the peptide–drug conjugate LN005 in liver S9s by UHPLC-Orbitrap-HRMS;Xenobiotica;2023-12-04